PTPI Dividend: Petros Pharmaceuticals Inc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

PTPI Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	5	5	5	5	7	9
Revenue Growth (YoY)	-57.99%	0%	0%	-28.99%	-22%	-40%
Cost of Revenue	1	1	1	2	1	4
Gross Profit	3	3	4	3	6	5
Selling, General & Admin	8	8	9	12	15	15
Research & Development	2	2	2	1	1	0
Operating Expenses	14	14	17	19	24	22
Other Non Operating Income (Expenses)	0	0	2	--	--	--
Pretax Income	-14	-14	-8	-20	-8	-22
Income Tax Expense	0	0	0	0	0	-1
Net Income	-26	-26	-13	-20	-8	-20
Net Income Growth	18%	100%	-35%	150%	-60%	-38%
Shares Outstanding (Diluted)	0.4	0.32	0.08	0.08	0.04	0.03
Shares Change (YoY)	-81%	269%	5%	90%	12%	0%
EPS (Diluted)	-66.27	-83.46	-158.71	-241.99	-206.38	-530.26
EPS Growth	547%	-47%	-34%	17%	-61%	-37%
Free Cash Flow	-2	-2	-7	-12	-11	-15
Free Cash Flow Per Share	-4.94	-6.23	-80.45	-144.92	-252.29	-386.59
Gross Margin	60%	60%	80%	60%	85.71%	55.55%
Operating Margin	-200%	-200%	-260%	-300%	-257.14%	-188.88%
Profit Margin	-520%	-520%	-260%	-400%	-114.28%	-222.22%
Free Cash Flow Margin	-40%	-40%	-140%	-240%	-157.14%	-166.66%
EBITDA	-8	-8	-10	-10	-12	-11
EBITDA Margin	-160%	-160%	-200%	-200%	-171.42%	-122.22%
D&A For EBITDA	2	2	3	5	6	6
EBIT	-10	-10	-13	-15	-18	-17
EBIT Margin	-200%	-200%	-260%	-300%	-257.14%	-188.88%
Effective Tax Rate	0%	0%	0%	0%	0%	4.54%